D. E. Shaw & Co., Inc. Adamas Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

  • $122 Billion
  • Q4 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
N/A
-293,428 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
N/A
-175,432 Reduced 37.42%
293,428 $1.44 Million
Q2 2021

Aug 16, 2021
BUY
N/A
110,968 Added 31.01%
468,860 $2.48 Million
Q1 2021

May 17, 2021
SELL
N/A
-318,234 Reduced 47.07%
357,892 $1.72 Million
Q4 2020

Feb 16, 2021
BUY
N/A
82,179 Added 13.84%
676,126 $2.93 Million
Q3 2020

Nov 16, 2020
BUY
N/A
409,847 Added 222.62%
593,947 $2.45 Million
Q2 2020

Aug 14, 2020
BUY
N/A
106,517 Added 137.29%
184,100 $471,000
Q1 2020

May 15, 2020
BUY
N/A
77,583 New
77,583 $224,000
Q4 2019

Feb 14, 2020
SELL
N/A
-71,724 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
N/A
71,724 New
71,724 $367,000
Q4 2017

Feb 14, 2018
SELL
N/A
-22,526 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
N/A
22,526
22,526 $477,000

About Adamas Pharmaceuticals, Inc.

ADMS Quotes by TradingView
  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email